Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer

Chang-Ching Lin1, Miao-Chia Lo1, Rebecca Moody2

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, 48109, USA.

Cancer Letters
|September 19, 2018
PubMed

Insights

Triple-negative breast cancer (TNBC) is hard to treat. This study finds LRP8 promotes cancer stem cells in TNBC, suggesting LRP8 as a new therapeutic target to improve treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Triple-negative breast cancer (TNBC) presents significant therapeutic challenges due to limited targeted treatments.
  • Breast cancer stem cells (BCSCs) are implicated in TNBC's chemoresistance and metastatic potential.

Purpose of the Study:

  • To identify novel regulators of BCSCs in TNBC.
  • To investigate the role of LRP8 in TNBC progression and therapeutic sensitivity.

Main Methods:

  • Expression analysis of LRP8 in breast cancer subtypes.
  • LRP8 knockdown in TNBC cell lines.
  • Assessment of Wnt/β-catenin signaling pathway activity.
  • Evaluation of BCSC populations and tumorigenic potential in xenograft models.
  • Analysis of cellular phenotype and chemosensitivity post-LRP8 knockdown.

Main Results:

  • LRP8 is highly expressed and its locus amplified in TNBC.
  • LRP8 knockdown inhibits Wnt/β-catenin signaling, reduces BCSCs, and suppresses tumor growth.
  • LRP8 inhibition promotes a differentiated phenotype and enhances chemotherapy sensitivity in TNBC cells.

Conclusions:

  • LRP8 acts as a positive regulator of BCSCs in TNBC.
  • Targeting LRP8 represents a promising therapeutic strategy for TNBC by suppressing BCSCs and overcoming chemoresistance.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.3K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K